Christoph Lengauer, Ph.D.


The most powerful thing about being a part of this industry is having the opportunity to improve the lives of patients and their families.

Christoph Lengauer

Christoph loves the ideation of new company concepts and focuses on the formation, development and strategy of our portfolio companies. He is an accomplished scientist and drug hunter with the ability to translate that knowledge, insight and expertise into compelling business strategies. Christoph has contributed to the discovery and development of four FDA-approved medicines and several drugs currently in clinical trials.

Christoph is dedicated to making a dramatic difference in patients’ lives. He is enthusiastic about Third Rock’s approach to discover, launch and build great companies by focusing on bold ideas that meet at the intersection of science, strategy, business and medicine. He is especially excited by initiatives at the firm focusing on the early detection of diseases, in order to not only treat but cure patients. By leveraging his experiences and networks from academia, pharma, and biotech, he hopes to continue building great teams that help our companies succeed with this important mission.

Over his career, Christoph has received numerous awards, including the Novartis Oncology’s President’s Award for Top Innovator and has been elected to membership in the Johns Hopkins Society of Scholars.

Year Joined
  • 2016
  • M.S., Human Genetics, University of Salzburg
  • Ph.D., Biology, Heidelberg University
  • MBA, Medical Services Management, Johns Hopkins University
Administrative Support
  • East Coast
Board Positions